Skip to content

OMDA OMDA Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

Teladoc Health logo
Teladoc HealthTDOC
Viking Therapeutics logo
Viking TherapeuticsVKTX
AdaptHealth logo
AdaptHealthAHCO
Mannkind logo
MannkindMNKD

Other financials

Income statement

See full
Revenue$78.0M+42.0%
Gross profit$48.7M+52.6%
Operating income-$4.8M+43.1%
Net income-$3.0M+68.6%
EPS (diluted)-$0.05+95.7%

Balance sheet

See full
Cash & equivalents$211.8M+257%
Total debt$30.0M
Total equity$234.1M+160%
Total assets$302.8M

Cash flow

See full
Operating cash flow-$11.8M+26.6%
CapEx$78.0K-75.2%
Free cash flow-$11.9M+27.5%

Valuation

See full
Market cap$1.11B+23.8%
P/S3.9×-0.4×

Profitability

See full
Gross margin66.3%+4.4pp
Operating margin-9.6%-4.0pp
Net margin-11.3%-4.6pp
FCF margin-40.8%

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.1×
Current ratio3.9×

Where this comes from

Reported directly by OMDA in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: OMDA’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OMDA's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OMDA's operating lease right-of-use asset amortization?
OMDA (OMDA) reported operating lease right-of-use asset amortization of $0 in Q1 2026.
How has OMDA's operating lease right-of-use asset amortization changed year-over-year?
OMDA's operating lease right-of-use asset amortization decreased by 100.0% year-over-year, from $189K to $0.